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Annexin V binds in a calcium-dependent manner to acidic phospholipids and exhibits ion channel activity in vitro. We are investigating mutants 
of annexin V by single channel measurements, X-ray crystallography and electron microscopy in order to understand the structure-function 
relationships of the ion channel activity. We describe here a method to obtain very pure recombinant annexin V required for such studies. The 
initial step is the mild opening of the bacterial cells by an osmotic shock. In the purification procedure, use is made of the reversible calcium-mediated 
binding of annexin V to liposomes. In the last purification step the protein is subjected to ion-exchange chromatography and elutes as a single peak 
free of any detectable contaminants. 
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1. INTRODUCTION 
Annexin V is a member of the annexin family of 
proteins, which share the common property of binding 
to acidic phospholipids in a calcium-dependent manner 
[l-4]. More than ten members of this family have been 
described. They are distinct from the ‘EF-hand’ family 
of proteins [5]. Annexins have been identified in higher 
and lower eukaryotes and constitute a significant 
amount of the cellular protein in a variety of cell types 
[3]. Their biochemical and immunological properties 
are closely related. Their sequence is composed of four 
(in the case of annexin VI eight) repeats, which are 
homologous [6]. The N-termini are diverse in sequence 
and different in length and can also be altered by alter- 
native splicing [7,8]. The in vivo role of the annexins is 
still unclear. It has been proposed that they are involved 
in anti-coagulation [9], anti-inflammatory processes 
[lo], participate in cell replication or differentiation [I l] 
and exocytosis [12]. Annexins catalyze membrane fu- 
sion in vitro and bind to components of the cytoskeleton 
[ 13,141. Annexin V and VII form voltage-gated ion 
channels in vitro [15-l 81. We have presented the three- 
dimensional structure of annexin V from human pla- 
centa at a resolution of 2.0 A [19,20]. The molecule, 
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which is almost entirely a-helical, has an overall flat, 
slightly curved shape, with two faces: a convex and a 
concave one. The calcium binding sites are at the convex 
face, whereas the N-terminus is located at the concave 
face. Each of the four repeats folds into a compact 
domain, consisting of five a-helices. The domains are 
arranged in a planar, cyclic array, surrounding a hydro- 
philic pore with charged residues and water molecules 
with a well-defined electron density. We suggested that 
the hydrophilic pore is the ion pathway [19,20]. We are 
studying the ion channel activity of human annexin V 
to get an insight into the structure-function relation- 
ships. We proposed that the annexin V molecule dis- 
turbs the membrane by electroporation, thereby making 
it ion permeable in an unspecific manner [21], while the 
selectivity for calcium resides in the protein moiety. Our 
approach is by site-specific mutagenesis and characteri- 
zation of the mutated protein by X-ray-crystallography, 
electron microscopy, spectroscopy and electrophysiol- 
ogical single channel measurements. For these biophys- 
ical methods, very pure protein is required. We describe 
here a simple, short and reliable method for obtaining 
pure recombinant annexin V, as judged by silver-stained 
SDS-PAGE and HPLC-profile analysis. The most im- 
portant improvement is the avoidance of the otherwise 
inevitable co-purification of other factors by the mild 
opening of the bacterial cells. 
Abbreviations: DNase, desoxyribonuclease; EDTA, ethylene diamine 
tetraacetic acid; E. coli, Escherichia coli; HPLC, high-pressure liquid 
chromatography; IPTG, isopropylthiogalactoside; PAGE, poly- 
acrylamide gel-electrophoresis; PMSF, phenylmethylsulfonyl f uo- 
ride; RNase, ribonuclease; SDS, sodium dodecyl sulfate; v/v, volume 
per volume; w/v, weight per volume. 
2. MATERIALS AND METHODS 
The expression vector, pTRC99A-PP4 [22], and the E. coli strain, 
W3 110, were a kind gift of the Behring Institutes, Marburg. Bacto- 
tryptone and yeast extract were from Difco, MI, USA. Pepstatin A, 
brain extract type III, bis-Tris and ampicillin were from Sigma, Deis- 
enhofen. IPTG was from Gerbu, Gaiberg. Lysozyme, RNase (bovine 
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pancreas) and DNase I were from B~h~n~r-Mannhe~, Mannhe~. 
The column material DEAE-Sepharose was from Pharmacia, 
Freiburg. All other reagents were from Merck, Darmstadt in the p.A. 
purity grade. 
2.1. Purification of recombinant annexin V 
An overnight culture of E. coli W3110, transformed with 
pTRC99A-PP4 grown at 33’C in LB medium with SOpg/ml ampicillin 
is diluted 5-fold into fresh LB medium. When the OD (optical density) 
at 600 nm has reached a value of 1.5-2, IPTG is added to a final 
concentration of 1 mM. After 24 h growth, the bacterial cells are 
harvested by centrifugation (5,000 x g, 15 min, 4’C). The cells are 
resuspended in spheroblast buffer (0.5 mM EDTA, 7.50 mM Sucrose, 
200 mM Tris, pH 8.0) and a solution of lysozyme in spheroblast buffer 
(10 mg/ml) is added to a final ~n~ntration of 1 mg/ml. Innately 
the 7-fold volume of Spheroblast buffer, diluted 1:l with water, is 
poured into the lyzozyme solution and the suspension is incubated on 
ice for 30 min under gentle shaking. The spheroblasts are collected by 
centrifugation (30 min, 14,000 x g, 4°C) and resuspended in ultracen- 
trifugation buffer (2 mM EDTA, 5 mM MgCl,, 100 mM NaCl, 0.1 
mg/ml RNase (bovine pancreas), 0.1 mg/ml DNase I, 2 mM PMSF, 
0.5&ml pepstatin A, 0.1% (w/v) Triton X-100,20 mM Tris, pH 8.0). 
The bacterial cells are opened by osmotic shock. To remove the cell 
debris the suspension is centrifuged at 100,000 x g overnight. 
Lyophilized brain extract containing 80-85% phosphatidylserine is 
dissolved in a mixture of chloroform/methanol, 2: 1, and dried down 
under a stream of nitrogen. It is redissolved in ether and dried down 
again. The phospholipid mixture is resuspended by vortexing in li- 
posome buffer (100 mM NaCl, 3 mM MgCl,, 20 mM Tris, pH 8.0) 
and sonicated for 15 mm. The su~matant of the ~t~entrifugation 
is carefully removed and combined with the liposomes. Then the 
solution is adjusted to an excess of 5 mM CaCl, and stirred for 30 min 
on ice. The mixture is ultracentrifuged for 45 min at 40,000 x g and 
4”C, the supematant is removed and the pellet washed with a solution 
of 5 mM CaCl,, 100 mM NaCl, 3 mM MgCl,, 20 mM Tris, pH 8.0 
and centrifuged (30 min, 50,000 x g, 4’C). The pellet is resuspended 
in 10 mM EDTA, 100 mM NaCl, 3 mM MgCl,, 20 mM Tris, pH 8.0, 
and the liposomes are removed by centrifugation for 1 h at 50,000 x g 
and 4°C. The supernatant isthen dialyzed against 20 mM b&T&, pH 
6.0, 0.02% (w/v) sodium azide. If there is any precipitate, consisting 
of degraded protein, it is removed by centrifugation (20,000 xg, 30 
min, 4°C). The protein solution is loaded on a DEAE-Sepharose 
column (Diameter 14 mm, bed height 150 mm) and washed with at 
least 3 column ~01s. of 20 mM his-Tris, pH 6.0. Then the protein is 
eluted with a linear NaCl gradient (O-200 mM) at a flow rate of about 
0.4 mUmin (see Fig. 1 for the elution profile). Annexin V elutes as a 
single peak between 80 and 90 mM NaCl. The yield is l-5 mg/l of E. 
coti culture. The purity of the protein is tested by SDS-PAGE and 
HPLC-profile analysis. Fig. 2 shows a 12% SDS-polyacrylamide gel 
[23], which has been silver-stained [24]. The purified protein also elutes 
as a single peak from a HPLC-column (see Fig. 3). 
2.2. HPLC analysis 
The HPLC system was composed of two pumps (Model 420, Kon- 
tron instrument) and a spectromonitor variable wavelength UV detec- 
tor (Spectroflow 757, Kratos Analytical Instrument) linked to a re- 
corder (Model BD41, Kipp & Zonen). HPLC analysis was performed 
on a C4 reverse-phase column (Nucleosil 250*4 5 pm; Macherey- 
Nagel) eluted with a linear gradient 30-708 (v/v) acetonitrile (Lichro- 
solv gradient grade; Merck, Darmstadt) in 0.1% (w/v) trifluoroacetic 
acid (Uvasol; Merck, Darmstadt) for 60 min at a flow rate of 1 mllmin. 
Detection was measured at 280 nm. 
3. RESULTS AND DISCUSSION 
There exist a variety of reports on the purification of 
members of the annexin family, most of them describing 
the purification of the proteins from eukaryotic cells, a 
few dealing with recombinant annexins (see for example 
[25-281). No purification procedure has been published 
so far yielding annexin which is pure on a silver-stained 
SDS-gel. The staining of proteins with silver salts is 
loo-to lOOO-fold more sensitive than the staining with 
Coomassie blue. We report here a purification proce- 
dure which uses the reversible calcium-mediated bind- 
ing of annexin V to liposomes, modified from previous 
approaches [27,29]. Our expression system yields solu- 
ble annexin V and no inclusion bodies. The first and 
very important step is the mild opening of the bacterial 
cells by an osmotic shock. Bacterial cell rupture by ul- 
trasonication or French press followed by purification 
steps, as described above did not yield pure protein. 
Annexin V bound a variety of impurities very tightly. 
These were not identified. The addition of deter- 
gents (lysophosphatidylcholine, sodium desoxycholate, 
SDS), denaturing agents (urea) or high concentrations 
of NaCl and chaotropic agents (KI) did not improve the 
situation (data not shown). 
When the cells were opened by m~h~ical shearing 
forces, the recombinant annexin V was not pyrogen free 
and still contained lipopolysaccharides (J. Roemisch, 
personal communication), which could indicate that 
components of the outer cell wall stick to annexin V. In 
order to avoid this, we prepared spheroblasts, which 
still have the inner cell wall intact. By the following 
loo 200 300 
Elution Volume m ml 
Fig 1. Elution profile of annexin V from a DEAE-Sepharose column with a linear NaCl gradient (dotted line) from O-200 mM. The single peak 
eluting between 80 and 90 mM NaCl contains annexin V and was analyzed by SDS-PAGE (see Fig. 2). 
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centrifugation step, soluble components were removed. 
The isolated spheroblasts were then resuspended in a 
buffer containing no sucrose, and were thereby opened 
by the osmotic shock. This mild opening should also 
ensure that only large membrane fragments are pro- 
duced. Tiny fragments, which cannot be removed by the 
following centrifugation, were largely avoided [30]. All 
components interacting with the inner cell membrane 
were spun down during the ultracentrifugation, a step 
which probably diminished the yield but was inevitable 
if a high grade of purity was to be obtained. Afterwards, 
liposomes of bovine brain extract type III were pre- 
pared, which has a high content of phosphatidylserine 
essential for annexin V membrane binding. The reversi- 
ble calcium binding step served as an affinity step and 
very selectively removed most of the other proteins as 
can be seen in Fig. 2. These liposomes were prepared 
from bovine brain extract, because a pure annexin V 
preparation was not achieved when using E. coli mem- 
branes in this affinity step. 
At this step the protein is not yet pure. In some prep- 
arations other protein bands were still detectable (not 
seen in Fig. 2), and also the ratio of the absorbance at 
260 nm to 280 nm was only about 1:l. The remaining 
contaminants were all removed in the last purification 
step with anion-exchange chromatography at pH 6.0, 
about one pH unit above the isoelectric point (4.8) of 
annexin V Most contaminants present did not bind to 
the column and were found in the flow through. Other 
contaminants remained bound to the column and eluted 
at much higher NaCl concentrations. 
12 3M 
I 66 kDa 
- 45 kDa 
- 36 kDa 
20 kDa 
Fig. 2. Silver-stained 12% SDS-polyacrylamide gel of the various pu- 
rification steps. The very faint protein bands with low molecular 
weight in lanes 2 and 3 are proteolytically degraded products of an- 
nexin V. Lane M, Marker Dalton VII-L (Sigma, Deisenhofen) with 
the indicated molecular masses (1 pup). Lane 1, cell extract after the 
ultracentrifugation step (diluted 1:20); lane 2, supematant after the 
treatment of liposomes with EDTA (1.2 pg protein); lane 3, annexin 
V, eluted from DEAE-Sepharose (see Fig. 1) (1.2 pug protein). 
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Fig. 3. HPLC analysis on a reverse-phase C4 column of annexin V 
(AU, arbitrary units). Peak 1 corresponds to the dead volume of the 
column and peak 2 to highly purified annexin V. The arrow indicates 
the starting point and the dashed line shows the acetonitrile gradient. 
By this method we reached reasonable yields, which 
are sufficient for our further studies. The purity is fur- 
ther underlined by the crystallization of the mutant pro- 
teins by the vapour diffusion method (Berendes et al., 
submitted for publication; Burger et al., manuscript in 
preparation). We obtained crystals, which diffract X- 
rays beyond 2.0 A resolution. Also two-dimensional 
crystallization has been successful and the protein was 
very active in single channel measurements (Berendes et 
al., submitted for publication; Burger et al., manuscript 
in preparation; Voges et al., manuscript in preparation). 
In summary, we can obtain very pure annexin V by 
opening the bacterial cells by osmotic shock and re- 
moval of the components of the E. coli cell wall. The 
affinity step of the calcium-mediated binding to li- 
posomes is a fast and efficient way to remove nearly all 
other proteins. The last chromatography step ensures 
the removal of further contaminants, yielding very pure 
material suitable for biophysical studies. 
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